Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma

被引：0
|
作者：
Xinglei Shen
Albert DeNittis
Maria Werner-Wasik
Rita Axelrod
Paul Gilman
Thomas Meyer
Joseph Treat
Walter J Curran
Mitchell Machtay
机构：
[1] Kimmel Cancer Center,Department of Radiation Oncology
[2] Jefferson Medical College of Thomas Jefferson University,Department of Radiation Oncology, Lankenau Hospital and Lankenau Institute for Medical Research
[3] Main Line Health System,Department of Medical Oncology, Kimmel Cancer Center
[4] Jefferson Medical College of Thomas Jefferson University,Department of Hematology/Oncology, Lankenau Hospital and Lankenau Institute for Medical Research
[5] Main Line Health System,Department of Radiation Oncology
[6] Eli Lilly,Department of Radiation Oncology
[7] Inc,undefined
[8] Emory University Hospital,undefined
[9] University Hospitals,undefined
来源：
Radiation Oncology | / 6卷
关键词：
Dose Level; Carboplatin; Esophagitis; Median Survival Time; Pemetrexed;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer
    Tsuchiya-Kawano, Yuko
    Sasaki, Tomonari
    Yamaguchi, Hiroyuki
    Hirano, Katsuya
    Horiike, Atsushi
    Satouchi, Miyako
    Hosokawa, Shinobu
    Morinaga, Ryotaro
    Komiya, Kazutoshi
    Inoue, Koji
    Fujita, Yuka
    Toyozawa, Ryo
    Kimura, Tomoki
    Takahashi, Kosuke
    Nishikawa, Kazuo
    Kishimoto, Junji
    Nakanishi, Yoichi
    Okamoto, Isamu
    ONCOLOGIST, 2020, 25 (06): : 475 - +
  • [32] Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer
    Omori, Shota
    Harada, Hideyuki
    Mori, Keita
    Hisamatsu, Yasushi
    Tsuboguchi, Yuko
    Yoshioka, Hiroshige
    Morinaga, Ryotaro
    Daga, Haruko
    Kurata, Takayasu
    Takahashi, Toshiaki
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 106 - 114
  • [33] Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer
    Shota Omori
    Hideyuki Harada
    Keita Mori
    Yasushi Hisamatsu
    Yuko Tsuboguchi
    Hiroshige Yoshioka
    Ryotaro Morinaga
    Haruko Daga
    Takayasu Kurata
    Toshiaki Takahashi
    Investigational New Drugs, 2022, 40 : 106 - 114
  • [34] A Phase I Study of Enzastaurin Combined with Pemetrexed in Advanced Non-small Cell Lung Cancer
    Tanai, Chiharu
    Yamamoto, Nobuyuki
    Ohe, Yuichiro
    Takahashi, Toshiaki
    Kunitoh, Hideo
    Murakami, Haruyasu
    Yamamoto, Noboru
    Nakamura, Yukiko
    Nokihara, Hiroshi
    Shukuya, Takehito
    Baldwin, John R.
    Koshiji, Minori
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (07) : 1068 - 1074
  • [35] Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer
    Okamoto, Isamu
    Takeda, Koji
    Daga, Haruko
    Miyazaki, Masaki
    Yonesaka, Kimio
    Kiyota, Hidemi
    Tsurutani, Junji
    Ueda, Shinya
    Ichikawa, Yasuko
    Takeda, Masayuki
    Sekiguchi, Risa
    Tominaga, Kiyomi
    Enatsu, Sotaro
    Nambu, Yoshihiro
    Nakagawa, Kazuhiko
    LUNG CANCER, 2010, 70 (02) : 168 - 173
  • [36] Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study
    Hoffman, PC
    Cohen, EEW
    Masters, GA
    Haraf, DJ
    Mauer, AM
    Rudin, CM
    Krauss, SA
    Huo, DZ
    Vokes, EE
    LUNG CANCER, 2002, 38 (01) : 65 - 71
  • [37] Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab for Japanese nonsquamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Hayashi, Mina
    Shimizu, Toshiki
    Nomura, Shosaku
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] PHASE I DOSE ESCALATION STUDY OF PEMETREXED AND CARBOPLATIN IN CHEMOTHEARPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER.
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Zaizen, Yoshiaki
    Shimamatsu, Fumie
    Azuma, Koichi
    Hoshino, Tomoaki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S859 - S859
  • [39] Phase I dose escalation study of pemetrexed and carboplatin in chemotherapy-naive elderly patients with advanced nonsquamous non-small cell lung cancer.
    Yamada, Kazuhiko
    Takeoka, Hiroaki
    Zaizen, Yoshiaki
    Shimamatsu, Fumie
    Azuma, Koichi
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] PHASE I DOSE ESCALATION STUDY OF PEMETREXED AND CARBOPLATIN IN CHEMOTHEARPY-NAIVE ELDERLY PATIENTS (≥ 75 YEARS) WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Yamada, Kazuhiko
    Takeoka, Hiroaki
    Yamashita, Fumie
    Zaizen, Yoshiaki
    Mizoguchi, Yusuke
    Azuma, Koichi
    Hoshino, Tomoaki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
12345